Biphenylsulfonamides as effective MMP‐2 inhibitors with promising antileukemic efficacy: Synthesis, in vitro biological evaluation, molecular docking, and MD simulation analysis

Documenti analoghi

• PROTAC‐Based HDAC Degradation: A Paradigm Shift in Targeted Epigenetic Therapies
  di: Ambati Himaja, et al.
  Pubblicazione: (2025)
• Synthesis, docking study, and antitumor evaluation of benzamides and oxadiazole derivatives of 3‐phenoxybenzoic acid as VEGFR‐2 inhibitors
  di: Mohammad H. Heriz, et al.
  Pubblicazione: (2024)
• Exploring Flavonoids as Regulators of MMP‐2 and MMP‐9 in Cancer Pathogenesis
  di: Ha Vy Thi Vo, et al.
  Pubblicazione: (2025)
• Exploring the cytotoxic potential of biflavones of Araucaria cunninghamii: Precise identification combined by LC‐HRMS‐metabolomics and database mining, targeted isolation, network pharmacology, in vitro cytotoxicity, and docking studies
  di: Bharat Sahu, et al.
  Pubblicazione: (2024)
• Design, synthesis, and biological evaluation of dinaciclib and CAN508 hybrids as CDK inhibitors
  di: Dana M. Odeh, et al.
  Pubblicazione: (2024)